Overexpression of GPX4 inhibits ferroptosis in CD8+ T cells and simultaneously restores the production of cytotoxic cytokines in vitro or increases the number of tumor-infiltrating CD8+ T cells in vivo, thereby enhancing tumor control (79–81). Here, GPX4 is linked to neoplasm.